X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dr. Reddys Fact Sheet, Dr. Reddys Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Fact Sheet   (REDY)

Here is the latest financial fact sheet of Dr. Reddys. For more details, see the Dr. Reddys quarterly results and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR. REDDYS LAB Price History

Price Rs 2,701.6
Mkt Cap Rs m 447,682
Vol '000 37.5
P/E X 34.6
P/CF X 14.3
EPS (TTM) Rs 78.0
% ch % -2.1
No. of shares m 165.71
% ch week % -0.1
% ch 1-mth % 0.6
% ch 12-mth % -25.3
52 week H/L Rs 3,639.6/2,382.1
(As on Jul 24, 2017 02:00:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR. REDDYS LAB Financials

No. of Mths
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
DR. REDDYS LAB EQUITY SHARE DATA
High Rs1,7711,9692,9403,6624,383 
Low Rs1,3871,5281,7662,2502,750 
Sales per share (Unadj.) Rs578.8700.4788.6881.8920.1 
Earnings per share (Unadj.) Rs76.789.9115.4137.1126.1 
Diluted earnings per shareRs78.592.1118.5141.0129.8 
Cash flow per share (Unadj.) Rs107.3122.3153.5181.7183.0 
Dividends per share (Unadj.) Rs13.7515.0018.0020.0020.00 
Adj. dividends per shareRs14.0715.3718.4820.5620.59 
Dividend yield (eoy) %0.90.90.80.70.6 
Book value per share (Unadj.) Rs294.2375.0462.4578.3685.8 
Adj. book value per shareRs301.1384.4474.6594.6706.1 
Shares outstanding (eoy) m169.56169.84170.11170.38170.61 
Bonus/Rights/Conversions  ESOPESOPESOPESOPESOP 
Price / Sales ratio x2.72.53.03.43.9 
Avg P/E ratio x20.619.520.421.628.3 
P/CF ratio (eoy) x14.714.315.316.319.5 
Price / Book Value ratio x5.44.75.15.15.2 
Dividend payout %17.916.715.614.615.9 
Avg Mkt Cap Rs m267,735296,965400,277503,643608,481 
No. of employees `00015.016.519.019.921.7 
Total wages/salary Rs m15,91219,28724,75429,44631,874 
Avg. sales/employee Rs Th6,543.07,209.57,060.77,565.77,244.4 
Avg. wages/employee Rs Th1,060.81,168.91,302.81,482.91,470.9 
Avg. net profit/employee Rs Th867.3925.31,033.31,176.6992.8 
DR. REDDYS LAB INCOME DATA
Net Sales Rs m98,145118,956134,153150,233156,978 
Other income Rs m1,3231,4991,6972,7412,693 
Total revenues Rs m99,468120,455135,850152,974159,671 
Gross profit Rs m24,31127,19532,50834,93634,587 
Depreciation Rs m5,1815,5026,4757,5999,705 
Interest Rs m1,0561,0031,2671,082824 
Profit before tax Rs m19,39722,18926,46328,99626,751 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-1,353-542000 
Tax Rs m5,0356,3796,8315,6325,237 
Profit after tax Rs m13,00915,26819,63223,36421,514 
Gross profit margin %24.822.924.223.322.0 
Effective tax rate %26.028.725.819.419.6 
Net profit margin %13.312.814.615.613.7 
DR. REDDYS LAB BALANCE SHEET DATA
Current assets Rs m69,99085,267103,257118,767118,201 
Current liabilities Rs m45,91456,58857,90468,21368,368 
Net working cap to sales %24.524.133.833.731.7 
Current ratio x1.51.51.81.71.7 
Inventory Days Days7267666260 
Debtors Days Days94989010097 
Net fixed assets Rs m41,20246,15952,79659,06072,265 
Share capital Rs m848849851852853 
"Free" reserves Rs m43,67756,36472,94692,735111,548 
Net worth Rs m49,89063,69178,65298,531117,009 
Long term debt Rs m16,41912,65920,75514,31510,690 
Total assets Rs m111,902134,872160,296185,978200,104 
Interest coverage x19.423.121.927.833.5 
Debt to equity ratio x0.30.20.30.10.1 
Sales to assets ratio x0.90.90.80.80.8 
Return on assets %12.612.113.013.111.2 
Return on equity %26.124.025.023.718.4 
Return on capital %28.829.727.926.721.6 
Exports to sales %49.351.355.249.446.3 
Imports to sales %9.49.78.99.09.0 
Exports (fob) Rs m48,40561,00474,05974,14672,618 
Imports (cif) Rs m9,19911,48711,95913,48514,050 
Fx inflow Rs m49,36764,29076,00774,87075,405 
Fx outflow Rs m15,29220,12524,60726,00827,115 
Net fx Rs m34,07544,16551,40048,86248,290 
DR. REDDYS LAB CASH FLOW
From Operations Rs m 16,126 13,779 19,697 25,235 40,476 
From Investments Rs m -18,884 -14,463 -16,941 -22,647 -19,421 
From Financial Activity Rs m 3,891 -1,568 -242 -4,332 -17,009 
Net Cashflow Rs m 1,133 -2,252 2,514 -1,744 4,046 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 25.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.4%
FIIs 35.3%
ADR/GDR 18.5%
Free float 15.3%
Shareholders 75,885
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034
E-MAIL spoddar@drreddys.com WEB www.drreddys.com
TELEPHONE (040) 4900 2222 FAX (040) 4900 2999
SECTOR PHARMACEUTICALS GROUP Dr. Reddy's Group
TR AGENT Bigshare Services Ltd., G-10, Left wing, Amrutha Ville, Hyderabad - 82
AUDITOR B. S. R & Co.
CHM: G. V. Prasad COMP SEC: Sandeep Poddar YEAR OF INC: 1984 BSE CODE: 500124 FV (Rs): 5 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   INDOCO REMEDIES  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  MERCK LTD  FULFORD INDIA  

Compare DR. REDDYS LAB With:   INDOCO REMEDIES  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  MERCK LTD  FULFORD INDIA  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty Hovers Near 10,000 Mark; Energy Stocks Witness Buying(01:30 pm)

After opening the day marginally higher, stock markets in India have continued their momentum. Presently, they are trading near their all-time high levels.

Views on news

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

The Impact of GST On Banking transactions, Insurance, and Investments(Outside View)

Jul 11, 2017

PersonalFN explains how GST impacts your insurance premiums, investments, and banking transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS